Tharimmune Stock Gains 30%, on $540M Capital Raise to Build Canton Coin Treasury Strategy

Tharimmune Stock Gains 30%, on $540M Capital Raise to Build Canton Coin Treasury Strategy

The nanocap biotech firm is pivoting into digital assets with a $540 million raise to build a canton coin–based treasury, backed by DRW and Liberty City Ventures.


Discover more from Stay Updated Finance News

Subscribe to get the latest posts sent to your email.

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *